|
May 22
|
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
|
|
May 8
|
Merus to Present at BofA Securities 2025 Health Care Conference
|
|
May 7
|
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 7
|
Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
|
|
May 7
|
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
|
|
Apr 18
|
Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?
|
|
Feb 13
|
Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit
|